Copyright
©The Author(s) 2019.
World J Gastroenterol. Oct 21, 2019; 25(39): 6025-6040
Published online Oct 21, 2019. doi: 10.3748/wjg.v25.i39.6025
Published online Oct 21, 2019. doi: 10.3748/wjg.v25.i39.6025
Figure 4 Total remission rates of peptic ulcers between allicin and control groups (intent-to-treat/per-protocol analysis).
The total remission rate across allicin groups was significantly higher than that of the control group for ITT/PP analyses [95.99% (359/374) vs 89.25% (332/372), odds ratio = 3.13, 95% confidence interval: 1.51-6.51, P = 0.002]. CI: Confidence interval.
- Citation: Si XB, Zhang XM, Wang S, Lan Y, Zhang S, Huo LY. Allicin as add-on therapy for Helicobacter pylori infection: A systematic review and meta-analysis. World J Gastroenterol 2019; 25(39): 6025-6040
- URL: https://www.wjgnet.com/1007-9327/full/v25/i39/6025.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i39.6025